The antifibrotic effect of Imatinib loaded CD44 targeted gold nanoparticles (Im-CD44-GNP) relies on alveolar macrophage regulation

F. Meloni (Pavia, Italy), M. Morosini (Pavia, Italy), V. Codullo (Pavia, Italy), V. Frangipane (Pavia, Italy), S. Magni (Pavia, Italy), H. Recalde (Pavia, Italy), S. Inghilleri (Pavia, Italy), G. Comolli (Pavia, Italy), E. Cova (Pavia, Italy), C. Montecucco (Pavia, Italy), M. Colombo (Milan , Italy), D. Prosperi (Milan , Italy)

Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Session: CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Session type: Poster Discussion
Number: 3660
Disease area: Interstitial lung diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Meloni (Pavia, Italy), M. Morosini (Pavia, Italy), V. Codullo (Pavia, Italy), V. Frangipane (Pavia, Italy), S. Magni (Pavia, Italy), H. Recalde (Pavia, Italy), S. Inghilleri (Pavia, Italy), G. Comolli (Pavia, Italy), E. Cova (Pavia, Italy), C. Montecucco (Pavia, Italy), M. Colombo (Milan , Italy), D. Prosperi (Milan , Italy). The antifibrotic effect of Imatinib loaded CD44 targeted gold nanoparticles (Im-CD44-GNP) relies on alveolar macrophage regulation. 3660

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: